Lymphoproliferative disorders are medical conditions in which excessive numbers of lymphocytes are produced. Lymphoproliferative disorders can be caused by inherited immunodeficiency syndromes or ...

US health technology assessor the Institute for Clinical and Economic Review (ICER) as released a Final Evidence Report ...

As several families are gathering this week for the holidays, unfortunately some are spending them at our area hospitals.

Therapies for EBV-positive posttransplant lymphoproliferative disease, breast cancer, Barth syndrome, pain, and migraine are under review.

Atara Biotherapeutics, Inc. disclosed in a recent 8-K filing with the Securities and Exchange Commission that on December 20, 2024, the Board of Directors approved the amendment and restatement of the ...

Fintel reports that on December 20, 2024, Rodman & Renshaw initiated coverage of Atara Biotherapeutics (NasdaqGS:ATRA) with a ...

Expert Rev Hematol. 2013;6(2):139-153.

It is possible that AtLP represent multiclonal B cells, T cells or NK-cell lymphoproliferative processes in which there is an existence of occult abnormal B-cell, T-cell or NK-cell clones.

Azacitidine is under clinical development by Bristol-Myers Squibb and currently in Phase II for Pancreatic Ductal Adenocarcinoma.

Before a patient presenting with massive hepatosplenomegaly, B symptoms and cytopenias the diagnosis of lymphoproliferative disease was strongly considered namely aggressive B or T-cell/natural killer ...

After hours: December 24 at 2:52:48 PM EST Loading Chart for ATRA ...